Skip to content

Self-monitoring and Reminder Texts to Increase Physical Activity After Cancer: a Pilot Randomized Controlled Trial

Self-monitoring and Reminder Texts to Increase Physical Activity After Cancer: a Pilot Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02966054
Acronym
Smart Pace
Enrollment
42
Registered
2016-11-17
Start date
2014-08-31
Completion date
2017-06-20
Last updated
2018-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon Cancer, Rectum Cancer

Brief summary

Epidemiologic data consistently indicate that colorectal cancer survivors can improve their quality-of-life and prognosis by engaging in physical activity. This study aims to build on this epidemiologic work and translate the findings to inform and change patient behavior. The specific aims are to: (1) Develop a mobile technology physical activity intervention among colorectal cancer patients who have completed therapy. (2) Conduct a 3-month pilot randomized controlled trial utilizing mobile technology to increase physical activity among 40 men and women who have completed standard cytotoxic chemotherapy for primary stage I-III colorectal cancer at the UCSF Helen Diller Family Comprehensive Cancer Center. Participants in the intervention arm will receive a Fitbit® for self-monitoring, interactive text messages, and educational print materials; participants in the control arm will receive educational print materials at baseline and will be given a Fitbit® after completion of the 3-mo. follow-up assessment.

Interventions

BEHAVIORALDigital Health Physical Activity Intervention Group

Print materials on exercise after cancer, Fitbit Flex for 12 weeks, and daily Text Messages for 12 weeks

Sponsors

University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* stage I-III colon or rectal adenocarcinoma * completed standard cytotoxic chemotherapy if medically indicated * be considered disease-free at baseline * be able to speak and read English * have no contra-indication to moderate to vigorous aerobic exercise * be able to walk unassisted * be inactive at baseline (\<150 min/week of moderate physical activity) * have access to a mobile phone * be able to navigate websites, fill out forms on the web, communicate by email, and have regular access to the internet

Design outcomes

Primary

MeasureTime frameDescription
Physical activity12-weeksChange in total physical activity assessed via ActiGraph GT3X+ accelerometers

Secondary

MeasureTime frame
Fitbit wear time (# days with data / # days of observation)12-weeks
Response to text messages (# of messages responded to / # of messages that asked for a response)12-weeks
Quality-of-life (SF--36)12-weeks
Colorectal cancer-specific quality-of-life (FACT-C)12-weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 3, 2026